Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Eonbio is 8.1% (elevated). The 2024 annual accounts show negative equity (€-5k) and a net result of €-667. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone8.1%
Elevated
0%0,5%1,5%4%10%≥25%
Young company
+No NACE activity registered
+Higher-failure-rate region
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Signals
1 signal · with evidenceNegative equity
Equity is negative for financial year 2024: liabilities exceed assets. This is the trigger point of the alarm-bell procedure (Belgian CAC).
View the annual accounts Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Filing behaviour
From the deposit records, complete market-wideDeadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 15 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-09-2025, 57 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
How we compute the deadline
The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | 26-09-2025 | 57 d late | 2025-00504335 |
| 31-12-2023 | 31-07-2024 | 03-10-2024 | 64 d late | 2024-00499334 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsMore than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-667+83.4%
Working capitalNot included in this filing
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 26-09-2025 with the NBB · fiscal year 2024 · volledig
€-667
+83.4%
23-24
€387k
0.0%
23-24
€-5k
-16.6%
23-24
€392k
+0.2%
23-24
€392k
+0.2%
23-24
-1.2%
-16.6%
23-24
-83.46
+14.1%
23-24
14.2%
-85.8%
23-24
-0.2%
+83.4%
23-24
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | - |
| Net profit | €-667 |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €387k |
| Equity | €-5k |
| Debt | €392k |
| of which ≤ 1y | €392k |
| of which > 1y | - |
| Working capital | - |
| Employees (FTE) | - |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | - |
| Quick ratio | - |
| Working capital ratio | - |
| Solvency | -1.2% |
| Debt / equity | -83.46 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -0.2% |
| ROE | 14.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | 0d |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €387k |
| Fixed assets | 21/28 | €387k |
| Intangible fixed assets | 21 | €387k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €387k |
| Equity | 10/15 | €-5k |
| Contributions / capital | 10/11 | €0 |
| Accumulated profits (losses) | 14 | €-5k |
| Amounts payable | 17/49 | €392k |
| Amounts payable within one year | 42/48 | €392k |
| Trade debts payable within one year | 44 | €0 |
| Income statement | ||
| Gross operating margin | 9900 | €-667 |
| Operating result | 9901 | €-667 |
| Result before taxes | 9903 | €-667 |
| Net result for the period | 9904 | €-667 |
| Result to be appropriated | 9905 | €-667 |
You are seeing the latest fiscal year only. 1 prior year (figures + ratios) is in a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computed40
/ 100
Weak
Computed from 3 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Directors
Directors & mandates
2 directorsCurrent directors & mandates
-
LEVAUX BertrandDirectorState Gazette act 25110274 (01-09-2025)Current01-01-2025 → present
Former directors (1)
-
Alexandre Cyrille Araze Mouradian deDirectorState Gazette act 25110274 (01-09-2025)Former- → 01-01-2025
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 12-01-2023 |
| Status | Active |
| Postal code | 1050 |
Structure & network
Locations & real estate
Registered office
from the Crossroads BankCannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Louizalaan 4801050 ElseneEstablishment units
1 locationEonbio
since 20232.351.825.970
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area2,791 m²
Buildings1
Building footprint1,235 m²
Volume (LiDAR)89,309 m³
Tallest building106.8 m · ±30 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21822R0227/00V003 | Brussels | 2,791 m² | 1 · 1,235 m² | 106.8 m · 30 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
1 acts All acts · 1
updated 11 months ago
2025
01-09-2025 1 director appointed, 1 resigning
- LEVAUX Bertrand, Bestuurder
- Alexandre Cyrille Araze Mouradian de, Bestuurder
Analysis
Snowflake analysis
financial profile on 5 axes63
/ 100
Strong profile, led by stability.
All 5 axes are computed from data Checked has read.
Health
40
Profitability
71
Solvency
50
Growth
58
Stability
94
Credit advice
verdict per customer and amountCompany registry
Company registry (CBE)
Crossroads BankNames & trade names
| Legal nameFR | Eonbio |
Registered office
Louizalaan 480
1050 Elsene, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.